Gilead Sciences
GILD
#129
Rank
HK$1.170 T
Marketcap
HK$943.62
Share price
-1.14%
Change (1 day)
32.74%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): HK$50.82

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is HK$50.75. In 2024 the company made an earnings per share (EPS) of HK$2.96 a decrease over its 2023 EPS that were of HK$35.42.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$50.821617.88%
2024HK$2.96-91.65%
2023HK$35.4223.98%
2022HK$28.57-25.86%
2021HK$38.534850%
2020HK$0.78-97.64%
2019HK$33.010.9%
2018HK$32.7118.71%
2017HK$27.56-64.88%
2016HK$78.47-18.45%
2015HK$96.2255.28%
2014HK$61.96296.02%
2013HK$15.6517.89%
2012HK$13.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
HK$101.43 99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$111.55 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$10.52-79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$34.80-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$85.55 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.39-73.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.26 60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$159.72 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.11 16.47%๐Ÿ‡บ๐Ÿ‡ธ USA